CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −5,565 | $5.42 | $30K | 170,700 |
| 2026-02-19 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award | +62,500 | 176,265 | ||
| 2026-02-19 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −7,851 | $5.11 | $40K | 113,765 |
| 2025-07-14 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,117 | $2.58 | $3K | 121,616 |
| 2025-02-27 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −6,912 | $2.92 | $20K | 77,770 |
| 2025-02-13 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,786 | $2.98 | $5K | 84,682 |
| 2024-07-15 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,104 | $6.03 | $7K | 86,468 |
| 2024-02-27 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award | +44,963 | 122,733 | ||
| 2024-02-20 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −2,593 | $5.53 | $14K | 82,058 |
| 2024-02-16 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award | +39,000 | 84,651 | ||
| 2024-02-16 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-02-12 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,809 | $5.54 | $10K | 45,651 |
| 2023-07-11 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,057 | $3.84 | $4K | 47,460 |
| 2023-02-16 | Lew Jennifer EVP & Chief Financial Officer | Grant or award | +18,975 | 48,517 | ||
| 2023-02-16 | Lew Jennifer EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +77,050 | 77,050 | ||
| 2023-02-14 | Lew Jennifer EVP & Chief Financial Officer | Sale | −166 | $6.30 | $1K | 29,542 |
| 2023-02-13 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,742 | $6.31 | $11K | 29,708 |
| 2022-07-11 | Lew Jennifer EVP & Chief Financial Officer | Grant or award | +9,375 | 23,875 |
Page 1 of 2 · 36 trades